The placebo used the same excipients as that used in IMP without active drug substance. The placebo was developed as film-coated tablet same in size and appearance to the IMP., BRENSOCATIB, BRENSOCATIB
INS1007-231
Phase 2 small_molecule active
Quick answer
The placebo used the same excipients as that used in IMP without active drug substance. The placebo was developed as film-coated tablet same in size and appearance to the IMP., BRENSOCATIB, BRENSOCATIB for Hidradenitis Suppurativa is a Phase 2 program (small_molecule) at Insmed Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Insmed Limited
- Indication
- Hidradenitis Suppurativa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active